论文部分内容阅读
目的 :分析和研究在呼吸系统感染中雾化吸入的临床治疗效果。方法 :选取我院在2014年5月-2015年5月期间收治的80例呼吸系统感染患者,所有患者都采用利巴韦林药物治疗,按照随机分配原则将所有患者分为参照组和研究组,各40例,其中参照组采用静脉滴注治疗,研究组患者采用雾化吸入治疗,观察和比较两组患者的临床疗效。结果 :参照组患者的治疗总有效率为77.50%,研究组患者的治疗总有效率为87.50%,由此可以看出,研究组患者的治疗有效率要明显高于参照组,p<0.05,差异比较具有统计学意义。结论 :采用雾化吸入在呼吸系统感染中的临床治疗效果较好,患者的症状明十显减轻,值得推广。
OBJECTIVE: To analyze and study the clinical effect of nebulized inhalation in respiratory infections. Methods: Eighty patients with respiratory infection were selected from our hospital from May 2014 to May 2015. All patients were treated with ribavirin. According to the principle of random distribution, all patients were divided into the reference group and the study group , 40 cases in each group. The reference group was treated by intravenous drip, and the study group was treated by nebulization. The clinical curative effect was observed and compared between the two groups. Results: The total effective rate was 77.50% in the reference group and 87.50% in the study group. It can be seen that the treatment efficiency of the study group was significantly higher than that of the reference group (p <0.05) The difference was statistically significant. Conclusion: The clinical effect of using inhalation of inhalation in respiratory infection is better, and the symptom of the patient is obviously reduced obviously. It is worth popularizing.